Leaving the study early · adults aged ≥ 16 years with PTSD
Internet‐based cognitive and behavioural therapy (I‐C/BT) showed no clear difference in dropouts compared with wait list (low certainty).
1 finding from 1 review
All‐cause mortality · adults (18 years of age or older) with hypertension‐induced left ventricular hypertrophy
It is very uncertain whether antihypertensive therapy changes all‐cause mortality compared with placebo or no treatment (very low certainty).
1 finding from 1 review
Cardiovascular events · adults (18 years of age or older) with hypertension‐induced left ventricular hypertrophy
It is very uncertain whether antihypertensive therapy changes cardiovascular events compared with placebo or no treatment (very low certainty).
1 finding from 1 review
Total serious adverse events · adults (18 years of age or older) with hypertension‐induced left ventricular hypertrophy
It is very uncertain whether antihypertensive therapy changes total serious adverse events compared with placebo or no treatment (very low certainty).
1 finding from 1 review
Heart failure hospitalisation (RR) · adults (18 years of age or older) with hypertension‐induced left ventricular hypertrophy
It is very uncertain whether antihypertensive therapy changes hospitalisation for heart failure compared with placebo or no treatment (very low certainty).
1 finding from 1 review
Withdrawals due to adverse events · adults (18 years of age or older) with hypertension‐induced left ventricular hypertrophy
It is very uncertain whether antihypertensive therapy changes withdrawal due to adverse events compared with placebo or no treatment (very low certainty).
1 finding from 1 review
Resolution at 12 to 24 weeks Quinell Grade (range 0 to 4, resolved disease is grade 0) · adults (> 18 years of age) with trigger finger
NSAID injection showed no clear difference in resolution at 12 to 24 weeks Quinell Grade (range 0 to 4, resolved… compared with glucocorticoid injection (low certainty).
1 finding from 1 review
Persistent moderate to severe symptoms at 12 to 24 weeks · adults (> 18 years of age) with trigger finger
NSAID injection may leads to higher persistent moderate to severe symptoms at 12 to 24 weeks compared with glucocorticoid injection (low certainty).
1 finding from 1 review
Recurrence · adults (> 18 years of age) with trigger finger
It is very uncertain whether NSAID injection changes recurrence at 12 to 24 weeks compared with glucocorticoid injection (very low certainty).
1 finding from 1 review
Total active motion · adults (> 18 years of age) with trigger finger
1 finding from 1 review
Post-operative pain (residual pain, any severity) · adults (> 18 years of age) with trigger finger
NSAID injection showed no clear difference in residual pain compared with glucocorticoid injection (low certainty).
1 finding from 1 review
Global assessment of treatment success · adults (> 18 years of age) with trigger finger
NSAID injection showed no clear difference in participant‐reported treatment success compared with glucocorticoid injection (low certainty).
1 finding from 1 review
Adverse events · adults (> 18 years of age) with trigger finger
It is very uncertain whether NSAID injection changes adverse events compared with glucocorticoid injection (very low certainty).
1 finding from 1 review
ADHD symptoms · adults with ADHD (available evidence for participants aged between 25 to 53 years old)
1 finding from 1 review
Clinical impression: severity ‐ not reported · adults with ADHD (available evidence for participants aged between 25 to 53 years old)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Clinical impression: improvement‐ not reported · adults with ADHD (available evidence for participants aged between 25 to 53 years old)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Anxiety · adults with ADHD (available evidence for participants aged between 25 to 53 years old)
1 finding from 1 review
Depression: investigator‐rated · adults with ADHD (available evidence for participants aged between 25 to 53 years old)
1 finding from 1 review
Harms: adverse events (poorly assessed and reported) · adults with ADHD (available evidence for participants aged between 25 to 53 years old)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
ADHD symptom severity: patient rated · adults with ADHD (available evidence for participants aged between 25 to 53 years old)
1 finding from 1 review